https://ipharmag.com/article/tau-mitochondrial-reverse-electron-transport-alzheimers iPharmag en 2026-08-07T03:27:38+00:00 How Tau Sabotages Brain-Cell Batteries — a New Clue to Alzheimer’s https://ipharmag.com/article/tarsus-acquires-alkeus-stargardt-eye-drug iPharmag en 2026-08-07T03:27:38+00:00 Tarsus to Buy Alkeus for Up to $800M, Betting on a Drug for a Rare Blinding Disease https://ipharmag.com/article/takeda-orzeyful-orexin-narcolepsy-approval iPharmag en 2026-08-07T03:27:38+00:00 FDA Approves Takeda’s Orzeyful, a First-in-Class Drug for Narcolepsy Type 1 https://ipharmag.com/article/schrodinger-bms-ai-drug-discovery-expansion iPharmag en 2026-08-07T03:27:38+00:00 Schrödinger and Bristol Myers Squibb Deepen Their AI Drug-Discovery Pact https://ipharmag.com/article/lifemine-263m-fungal-organ-transplant-drug iPharmag en 2026-08-07T03:27:38+00:00 LifeMine Raises $263M to Mine Fungi for a Safer Organ-Transplant Drug https://ipharmag.com/article/interneuron-transplants-repair-breathing-spinal-injury iPharmag en 2026-08-07T03:27:38+00:00 Transplanted Human Neurons Rebuilt Breathing Circuits in Injured Rats https://ipharmag.com/article/hinge-health-acquires-cylinder-gi-care iPharmag en 2026-08-07T03:27:38+00:00 Hinge Health Buys Cylinder for $105M, Adding Digital Digestive Care https://ipharmag.com/article/genetic-cause-back-pain-disc-degeneration iPharmag en 2026-08-07T03:27:38+00:00 Zebrafish Reveal the Biology Behind a Leading Cause of Back Pain https://ipharmag.com/article/fda-approves-tudriqev-oncolytic-virus-melanoma iPharmag en 2026-08-07T03:27:38+00:00 FDA Approves Tudriqev, an Engineered Cancer-Killing Virus for Advanced Melanoma https://ipharmag.com/article/algae-dha-powder-gates-foundation-award iPharmag en 2026-08-07T03:27:38+00:00 Gates Foundation Backs Cheap Algae-Grown Omega-3 for Mothers in Poorer Countries https://ipharmag.com/article/novo-nordisk-large-ma-strategy-pipeline iPharmag en 2026-08-06T08:51:00+00:00 Novo Nordisk Rules Out Big M&A for Now as It Works to Steady Its Pipeline https://ipharmag.com/article/moderna-mrna-flu-vaccine-fda-approval iPharmag en 2026-08-06T08:51:00+00:00 FDA Approves Moderna’s mFlusiva, the First mRNA Flu Vaccine https://ipharmag.com/article/dronabinol-thc-ptsd-nightmares-trial iPharmag en 2026-08-06T08:51:00+00:00 A Cannabis-Derived Drug Ended PTSD Nightmares for Over a Third of Patients in a Trial https://ipharmag.com/article/covid-reactivates-dormant-viruses-long-covid iPharmag en 2026-08-06T08:51:00+00:00 Severe COVID Can Reawaken Dormant Viruses, Offering a New Clue to Long COVID https://ipharmag.com/article/braveheart-cardiac-myosin-hcm-ipo iPharmag en 2026-08-06T08:51:00+00:00 Braveheart Bio Raises $382M in IPO for a China-Licensed Heart Drug